目的：基于中医传承辅助平台（V2.0）软件，分析中国期刊全文数据库（CNKI）中以中医药治疗乳腺癌的用药规律。方法：收集并筛选CNKI中以中医药治疗乳腺癌的相关文献，建立数据库，采用软件集成的数据挖掘方法，对筛选出的方剂进行频次统计、用药模式及组方规则分析，并在核心药物组合的基础上演化出新处方。结果：筛选出中医药治疗乳腺癌方剂169首，涉及中药265味，得出药物出现频次以补益药最高，在此基础上统计常用药对及组合规律，并得到新处方4个。结论：中医药治疗乳腺癌是在辨证论治的基础上，以扶正为本，同时以清热解毒类、化痰软坚类、活血化瘀类中药祛除诱因，体现了乳腺癌治疗中“病证结合”的原则。

This study aimed at explaining the TCM medication principles of breast cancer collected in CNKI by traditional Chinese medicine inheritance system(V2.0).TCM literatures over the treatments of breast cancer were collected and selected from CNKI.On this basis,a prescription database was built,and frequencies,medicine pattern and the rules of the prescriptions were analyzed using the data mining method of software integration to output new prescriptions according to the core medication group.As a result,one hundred and ninety-four TCM prescriptions for the treatment of breast cancer were screened out,involving 265 Chinese medicines,among which tonic medicines were used most frequently.Then,the commonly used medicines and rules were analyzed to achieve 4 new prescriptions.In conclusion,syndrome differentiation and treatment was primary in the TCM treatment of breast cancer,taking strenthening the body resistance as the main treatment with the adjuvent treatments of clearing away heat and toxic materials,promoting blood circulation to remove blood stasis and reducing phlegm and resolving masses to eliminate the cause,embodying the principle of“integration with disease and syndrome”in the treatment of breast cancer.

科学技术部国家重点基础研究发展计划“973计划”（2013CB532005）：基于框架理论的方剂体系梳理，负责人：沈涛。